Context: Information regarding the impact of parental multiple endocrine neoplasia type 1 (MEN 1) on neonatal outcomes is limited to case reports.
Objective: To determine the impact of parental MEN 1 on neonatal outcomes.
Methods: Retrospective cohort analysis of the Tasman 1 MEN 1 kindred stratified by whether birth occurred before (‘historical cohort’) or after (‘contemporary cohort’) prospective screening commenced. The historical cohort included kindred members born between 1825-1984 (n=341 children with a MEN 1 positive (MEN 1+) parent and n=314 children with MEN 1 negative (MEN 1-) parents). The contemporary cohort included all neonates (n=52) of MEN 1+ women (n=28) born at a tertiary referral hospital between 1985-2018. Data was retrieved from births, deaths and marriages registries, medical records and the Australian Institute of Health and Welfare.
Results:
Historical cohort: compared to MEN 1- parents, children of MEN 1+ parents were more likely to die before 15 years of age in multivariable analysis (HR 4.6, p=0.005). Excess mortality was attributable to children of MEN 1+ mothers (HR 4.52, p=0.021) and fathers (HR 3.76, p=0.029) and primarily accrued postpartum (HR 4.48, p=0.039 at 3 months). Deaths due to neoplasia were not significantly increased (1 vs 0 death, p=1.0).
Contemporary cohort: neonates of MEN 1+ mothers were more likely to be low birth weight (28.9% vs 6.7%, p=0.01), admitted to a higher care nursery (40.4% vs 17%, p=0.02) and had a longer median postnatal length of stay (5 vs 4 days, p=0.009) compared to the Australian average. Neonatal hypoglycemia (76%) and infection (15%) occurred frequently whereas hypocalcemia requiring intravenous calcium treatment did not (3.8%). Isolated antenatal hypercalcemia did not significantly alter neonatal outcomes.
Conclusion:
Children of MEN 1+ parents are disproportionately vulnerable and most at risk postpartum. The excess risk was not attributable to maternal MEN 1 or antenatal hypercalcemia alone.